Your browser is no longer supported. Please, upgrade your browser.
NOVN Novan, Inc. daily Stock Chart
Novan, Inc.
Index- P/E- EPS (ttm)-1.01 Insider Own32.34% Shs Outstand26.77M Perf Week3.31%
Market Cap17.98M Forward P/E- EPS next Y-0.79 Insider Trans0.00% Shs Float18.28M Perf Month-76.10%
Income-26.30M PEG- EPS next Q-0.41 Inst Own5.60% Short Float4.64% Perf Quarter-71.67%
Sales7.60M P/S2.37 EPS this Y78.90% Inst Trans- Short Ratio2.27 Perf Half Y-74.17%
Book/sh-1.05 P/B- EPS next Y53.60% ROA-79.50% Target Price1.00 Perf Year-54.93%
Cash/sh0.58 P/C1.16 EPS next 5Y- ROE233.90% 52W Range0.61 - 3.72 Perf YTD-78.75%
Dividend- P/FCF- EPS past 5Y-3.60% ROI-216.40% 52W High-81.95% Beta1.92
Dividend %- Quick Ratio1.30 Sales past 5Y17.20% Gross Margin- 52W Low9.88% ATR0.21
Employees48 Current Ratio1.30 Sales Q/Q116.70% Oper. Margin- RSI (14)27.25 Volatility8.23% 9.65%
OptionableNo Debt/Eq- EPS Q/Q-17.90% Profit Margin- Rel Volume4.63 Prev Close0.71
ShortableYes LT Debt/Eq- EarningsFeb 11 BMO Payout- Avg Volume372.73K Price0.67
Recom2.20 SMA20-57.14% SMA50-65.06% SMA200-68.99% Volume1,726,422 Change-5.26%
Jan-06-20Downgrade Piper Jaffray Overweight → Neutral
Jan-06-20 10:06AM  Company News For Jan 6, 2020 Zacks
Jan-03-20 02:28PM  Novan to press ahead despite poor trial results, big stock drop American City Business Journals -73.05%
09:28AM  Novan stock tumbles on failed trial MarketWatch
07:55AM  The Daily Biotech Pulse: Acorda Surges As Point72 Hikes Stake, Novan Sinks On Failed Study, Illumina-Pac Bio Terminate Merger Benzinga
Jan-02-20 04:15PM  Novan Reports Top-Line Efficacy Results from Phase 3 Trials of SB206 for Molluscum Contagiosum GlobeNewswire
Dec-18-19 02:50PM  Novan taps tested leader to be next CEO American City Business Journals +8.80%
08:00AM  Novan Announces Planned Chief Executive Officer Transition GlobeNewswire
Dec-06-19 12:29PM  Does Novan, Inc. (NASDAQ:NOVN) Have A Volatile Share Price? Simply Wall St.
Nov-30-19 09:38AM  Should You Buy Novan, Inc. (NOVN)? Insider Monkey
Nov-19-19 06:19AM  Medicines Co. shares jump 17% in premarket after report of potential Novartis offer MarketWatch
Oct-28-19 10:32AM  Analysts Estimate Novan (NOVN) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-22-19 09:54AM  Novartis net income climbs as drug sales grow MarketWatch
Oct-18-19 08:30AM  Novan Further Expands its Proprietary Nitric Oxide Platform GlobeNewswire
Oct-08-19 08:30AM  Novans Phase 2 SB206 Molluscum Study Published in Journal of the American Academy of Dermatology GlobeNewswire
Sep-20-19 08:30AM  Novan Awarded Approximately $1.1 Million Grant by Department of Defense GlobeNewswire
Sep-11-19 04:05PM  Novan Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Sep-05-19 01:25PM  Triangle pharma strikes deal to sell up to $25M of its stock American City Business Journals +15.21%
Sep-03-19 04:05PM  Novan Hires Michelle Patterson as Vice President of Project Management GlobeNewswire
09:00AM  Novan to Participate in H.C. Wainwright 21st Annual Global Investment Conference GlobeNewswire
Aug-14-19 10:26AM  Lean-running Triangle drugmaker to drastically shrink its office space American City Business Journals
08:15AM  Novan Advances Womens Health Business Unit with Non-Dilutive Funding GlobeNewswire
Aug-13-19 04:15PM  Novan Takes Steps to Reduce Real Estate Footprint GlobeNewswire
08:15AM  Novans Phase 3 Molluscum Pivotal Program Completes Enrollment GlobeNewswire
Aug-07-19 10:30AM  Analysts Estimate Novan (NOVN) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-24-19 08:30AM  Novans Drug Substance Demonstrates Inhibition of HPV-18 Virus Production GlobeNewswire
Jul-11-19 08:15AM  Novan SB206 Phase 3 Molluscum Pivotal Program Update GlobeNewswire
Jun-27-19 06:47AM  Does Market Volatility Impact Novan, Inc.'s (NASDAQ:NOVN) Share Price? Simply Wall St.
06:28AM  Is Novan, Inc. (NASDAQ:NOVN) A Volatile Stock? Simply Wall St.
Jun-19-19 08:15AM  Novan Expands External Business Partner Network GlobeNewswire
Jun-13-19 09:15AM  Novan to Participate in JMP Securities Life Sciences Conference GlobeNewswire
Jun-07-19 06:48AM  Is WisdomTree International High Dividend Fund (DTH) a Strong ETF Right Now? Zacks
Jun-06-19 04:15PM  Novan Achieves Compliance with Nasdaq Listing Rule 5450(b)(2)(A) GlobeNewswire +13.69%
Jun-04-19 06:30AM  First Patient Enrolled and Dosed in Novans SB206 Phase 3 Molluscum Program GlobeNewswire
May-31-19 04:15PM  Novan Announces 2019 Annual Meeting of Stockholders for July 31, 2019 GlobeNewswire +8.52%
May-30-19 01:00PM  Executive Voice: She raises cash, and hope, for struggling Novan American City Business Journals +15.54%
May-16-19 08:26AM  Is WisdomTree International High Dividend Fund (DTH) a Strong ETF Right Now? Zacks
May-15-19 02:35PM  With a fresh $30 million, Durham pharma set to expand drug pipeline American City Business Journals
May-07-19 04:15PM  Novan to Present Clinical Data at Annual Meeting of the Society for Investigative Dermatology GlobeNewswire
06:19AM  Europe markets sinking again on trade war escalation MarketWatch
May-06-19 02:52PM  Novan adds more cash, now confident it can execute American City Business Journals
09:00AM  Novan Completes Funding Transaction with Ligand Pharmaceuticals GlobeNewswire
May-01-19 08:15AM  Novan Confirms Corporate Update Conference Call and Webcast GlobeNewswire -19.46%
Apr-30-19 07:29AM  Cash-starved Novan adds capital, but at a price American City Business Journals +98.59%
Apr-29-19 04:15PM  Novan Secures Up to $35 Million in Non-Dilutive Funding GlobeNewswire -12.75%
Apr-09-19 05:19AM  European markets tick higher despite U.S. tariffs threat MarketWatch
Mar-29-19 02:35PM  Novan stock plummets as Durham company searches for additional financing American City Business Journals -7.27%
Mar-19-19 10:30AM  Will NOVAN INC (NOVN) Report Negative Q4 Earnings? What You Should Know Zacks +12.82%
09:00AM  Novan and Sato Advance Japan Market and Dermatology Partnership GlobeNewswire
Mar-11-19 08:00AM  Novan Completes End-of-Phase 2 Meeting and Provides Additional Business Updates GlobeNewswire +7.41%
Mar-07-19 07:01AM  Is WisdomTree International High Dividend Fund (DTH) a Strong ETF Right Now? Zacks
Mar-05-19 01:17AM  Novartis Cosentyx® shows superior improvements in psoriasis patients' quality of life versus Janssen's IL-23 Stelara®* GlobeNewswire
Mar-04-19 01:16AM  Novartis data confirm rapid response and high efficacy of Cosentyx® in psoriasis patients for first time in China GlobeNewswire
Feb-28-19 07:52AM  Novartis shareholders approve all resolutions proposed by the Board of Directors at the Annual General Meeting GlobeNewswire
Feb-25-19 05:57PM  Novartis issues summary financial information for the Alcon eye care business ahead of shareholder vote on proposed spin-off GlobeNewswire
01:16AM  Novartis to pursue transformational therapy to reduce risk of cardiovascular disease in people living with elevated levels of inherited lipoprotein(a) GlobeNewswire
Feb-13-19 04:25PM  Novartis receives FDA approval for Egaten® for the treatment of fascioliasis, a neglected tropical disease GlobeNewswire
Feb-12-19 07:41AM  Is WisdomTree International High Dividend Fund (DTH) a Strong ETF Right Now? Zacks
Jan-30-19 04:15PM  Novan Provides Business Update GlobeNewswire
Jan-23-19 02:59PM  Novan faces delisting from Nasdaq American City Business Journals
Jan-11-19 07:02PM  Cramer's Exec Cut: The biggest names in healthand Apple... CNBC Videos -6.19%
Jan-07-19 06:40PM  Novartis CEO on chasing cures over profitable treatments CNBC Videos +6.00%
Jan-02-19 02:33PM  Novan shakes up leadership again American City Business Journals +18.07%
06:15AM  Novan Announces Management Changes and Provides Business Update GlobeNewswire
Dec-28-18 07:22AM  Is WisdomTree International High Dividend Fund (DTH) a Strong ETF Right Now? Zacks
Dec-27-18 09:23AM  Stocks down in December for pharma firms in the Triangle American City Business Journals
Dec-20-18 11:25AM  Can We See Significant Insider Ownership On The Novan, Inc. (NASDAQ:NOVN) Share Register? Simply Wall St. -7.48%
Dec-11-18 09:22AM  Novan Announces Top-Line Data From Mid-Stage Molluscum Study Zacks +19.05%
08:00AM  Novan to Present Data from SB414 Phase 1b Atopic Dermatitis Clinical Trial at 3rd Inflammatory Skin Disease Summit GlobeNewswire
Dec-10-18 07:30AM  Novan Announces Full Top Line Results from Phase 2 Molluscum Contagiosum Clinical Trial and Decision to Move Forward with SB206 12% Once-Daily GlobeNewswire -9.35%
Dec-06-18 07:32AM  Is WisdomTree International High Dividend Fund (DTH) a Hot ETF Right Now? Zacks -16.14%
Nov-20-18 08:05AM  Novan to Present at Piper Jaffray 30th Annual Healthcare Conference GlobeNewswire -9.79%
Nov-19-18 06:46PM  Sandoz and Pear Therapeutics announce launch of reSET® for treatment of patients with Substance Use Disorder GlobeNewswire
08:45AM  Consolidated Research: 2018 Summary Expectations for Moleculin Biotech, Novan, PAVmed, Maui Land & Pineapple, Hallmark Financial Services, and McEwen Mining Fundamental Analysis, Key Performance Indications GlobeNewswire
Nov-14-18 06:30AM  Novan Phase 2 Molluscum Contagiosum Trial Achieves Statistical Significance in Preliminary Top Line Results GlobeNewswire
Nov-12-18 03:20PM  Novan (NOVN) Reports Q3 Loss, Lags Revenue Estimates Zacks
08:05AM  Novan Announces Corporate Update Conference Call and Webcast GlobeNewswire
Nov-05-18 02:29PM  The most valuable public companies in the Triangle (Slideshow) American City Business Journals
Nov-01-18 08:05AM  Novan Publication Supports Womens Health Business Unit Initiative and Nitric Oxides Potential Against HPV-Associated Diseases GlobeNewswire
Oct-25-18 07:05AM  Novan Creates Dedicated Womens Health Business Unit GlobeNewswire
Oct-18-18 12:53AM  European markets open mixed as Brexit talks rumble on CNBC -5.84%
Oct-16-18 08:05AM  Novan Extends Technical Production Capacity and Reaches Agreement with Orion Corporation GlobeNewswire +11.03%
Oct-08-18 12:12PM  Novan scores $11M with partnership with Japanese pharma American City Business Journals
08:00AM  Novan Expands Nitric Oxide Dermatology Business Partnership with Sato in Japan GlobeNewswire
Oct-01-18 08:05AM  Novans Phase 2 Molluscum Contagiosum Trial Fully Enrolled: Top Line Results Targeted in November GlobeNewswire
Sep-27-18 01:12PM  Novartis strikes deal with Chinese firm to make Kymriah Reuters
06:30AM  Novan Sees Hammer Chart Pattern: Time to Buy? Zacks
Sep-26-18 12:54PM  Before You Buy Novan Incs (NASDAQ:NOVN), Consider This Simply Wall St.
Sep-25-18 08:30AM  The Daily Biotech Pulse: Syndax Lung Cancer Trial Disappoints, Gemphire To Trim Workforce, Opiant's Offering Benzinga -5.67%
Sep-24-18 04:15PM  Novan Receives FDA Guidance for SB204 and Acne Indication GlobeNewswire
Aug-21-18 08:40AM  The Daily Biotech Pulse: Merck's Keytruda Secures Approval For Expanded Label, ProPhase Labs Q2 Loss Narrows Benzinga
Aug-20-18 11:44AM  Novan Rallies On Positive Early Results For Inflammatory Skin Disease Medication Benzinga
06:30AM  Novan Announces Promising Clinical Results with SB414 GlobeNewswire
Aug-08-18 12:45PM  New Novan incentive plan targets share price goals and $25M, $50M bonus pools American City Business Journals
08:25AM  Novan Provides Business Update via 10-Q, Adopts Incentive Plan and Agrees to CEO Contract GlobeNewswire
Jul-16-18 07:06AM  Novartis had longer and more detailed relationship with Trump lawyer Michael Cohen, Senate report finds MarketWatch
Jun-13-18 08:05AM  Novan to Participate in Upcoming Investor Conferences GlobeNewswire
Jun-07-18 01:54PM  Does Novan Incs (NASDAQ:NOVN) Earnings Growth Make It An Outperformer? Simply Wall St.
Jun-01-18 08:05AM  Novan Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
May-17-18 08:05AM  SB208 Increases Daily Nail Growth Rate over Four Weeks of Treatment GlobeNewswire
May-15-18 08:10AM  Novan Provides Update on SB414 Inflammatory Skin Disease Development Program GlobeNewswire
Novan, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of nitric oxide-based therapies to treat dermatological and oncovirus-mediated diseases. Its clinical stage product candidates include SB204, a topical monotherapy that is in Phase III pivotal clinical trials for the treatment of acne vulgaris; and SB206, a topical antiviral gel, which is in Phase III pivotal trials for the treatment of patients with external genital warts, and Phase II clinical trial for the treatment of molluscum contagiosum. The company's clinical stage product candidates comprise SB208, a topical antifungal gel that is in Phase II proof-of-concept trial for the treatment of athlete's foot and fungal nail infections; and SB414, a topical cream, which is in Phase Ib trial for the treatment of inflammatory skin diseases, such as psoriasis and atopic dermatitis. It has a license agreement with Sato Pharmaceutical Co., Ltd.; and a strategic alliance with Orion Corporation. Novan, Inc. was founded in 2006 and is headquartered in Morrisville, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Malin Life Sciences Holdings L10% OwnerJul 02Sale2.756,28717,2892,598,485Jul 02 09:45 PM
Malin Life Sciences Holdings L10% OwnerJul 01Sale2.749132,5022,604,772Jul 02 09:45 PM
Malin Life Sciences Holdings L10% OwnerJun 28Sale2.6917,80047,8822,605,685Jul 02 09:45 PM
Martin G. KellyChief Executive OfficerMay 29Buy1.971,5002,95545,000May 30 05:25 PM
Martin G. KellyChief Executive OfficerMay 28Buy2.153,5007,52543,500May 29 09:00 AM
PALMOUR JOHN WDirectorMay 24Buy2.2020,00044,000293,568May 29 08:59 AM
INGRAM ROBERT ALEXANDERDirectorMay 22Buy2.2150,000110,500169,777May 23 08:31 AM
Geer W KentDirectorMay 21Buy1.905,0009,50015,828May 23 08:32 AM
STAFFORD PAULA BPresident and COOMay 20Buy1.9280,000153,60080,693May 21 04:52 PM
NOVAK ANDREWVP, Accounting and Bus OpsMay 17Buy1.475,4007,9386,700May 21 04:54 PM
GAY JOHN M.VP, Finance & Corp. ControllerMay 17Buy1.5014,90022,35015,000May 21 04:53 PM
STAFFORD PAULA BPresident and COOMay 17Buy1.496931,033693May 21 04:52 PM
Martin G. KellyChief Executive OfficerMay 17Buy1.4340,00057,20040,000May 21 04:51 PM
Martin G. KellyChief Executive OfficerMay 17Buy1.4320,00028,60060,000May 21 04:51 PM